Compound information
- Natural Products
- ZC1373923
- Molecular Formula
- C19H24N4O2
- Molecular Weight
- 340.189926008 g/mol
- Structure
-
- IUPAC Name
- N-(4-ethoxyphenyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C19H24N4O2/c1-2-25-18-7-5-17(6-8-18)21-19(24)23-12-10-22(11-13-23)15-16-4-3-9-20-14-16/h3-9,14H,2,10-13,15H2,1H3,(H,21,24)
- InChI Key
- GKCKKNXUCWQQNK-UHFFFAOYSA-N
- SMILES
- CCOc1ccc(NC(=O)N2CCN(Cc3cccnc3)CC2)cc1
- Source
- ZINC000013324355
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 57.7 Å2 | LogP | 1.995 |
LogS | -3.006 | LogD | 2.426 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.128 | Pgp substrate | 0.867 |
HIA | 0.96 | F20 % | 0.989 |
F30 % | 0.862 | Caco-2 | -4.785 |
MDCK | -4.772 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.212 | PPB | 50.937 |
VD | 1.308 | Fu | 0.415 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.061 | CYP1A2 substrate | 0.759 |
CYP2A6 substrate | 0.794 | CYP2B6 substrate | 0.692 |
CYP2C19 inhibitor | 0.671 | CYP2C19 substrate | 0.803 |
CYP2C8 substrate | 0.799 | CYP2C9 inhibitor | 0.767 |
CYP2C9 substrate | 0.991 | CYP2D6 inhibitor | 0.764 |
CYP2D6 substrate | 0.998 | CYP2E1 substrate | 0.906 |
CYP3A4 inhibitor | 0.097 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.683 | CL | 12.722 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.844 | Hepatotoxicity | 0.53 |
Mutagenicity | 0.003 | Rat Oral Acute Toxicity | 0.829 |
FDAMDD | 0.316 | Skin Sensitization | 0.968 |
Carcinogenicity | 0.12 | Eye Corrosion | 0.001 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.909 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.707 | IGC50 | 3.25 |
LC50FM | 0.865 | LC50DM | -3.764 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.392 | NR-AR-LBD | 0.209 |
NR-AhR | 0.788 | NR-Aromatase | 0.036 |
NR-ER | 0.411 | NR-ER-LBD | 0.355 |
NR-PPAR-gamma | 0.163 | SR-ARE | 0.866 |
SR-ATAD5 | 0.418 | SR-HSE | 0.181 |
SR-MMP | 0.027 | SR-p53 | 0.123 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.